申请人:Toray Industries, Inc.
公开号:US05527940A1
公开(公告)日:1996-06-18
The present invention relates to a methanediphosphonate derivative, its manufacturing process and pharmaceutical applications, that is represented with the following formula: ##STR1## (wherein, B is either hydrogen, an alkyl group, hydroxyl group, alkoxy group or amino group, D is either sulfur, oxygen, NH, alkyl-substituted N, CH.sub.2 or SCH.sub.2, X represents an alkyl group, alkyl group having a hetero atom as a substitution group, an aryl group or an acyl group, m represents an integer of 1 to 5, and R.sup.1, R.sup.2, R.sup.3 and R.sup.4 independently represent hydrogen, alkyl groups having 1 to 7 carbon atoms or pharmaceutically allowable cations). The compound of the present invention has excellent IL-1 inhibitory action, antioxidation action and bone resorption inhibitory action, and is useful as an antiinflammatory agent, antirheumatic, bone metabolic disease drug, autoimmune disease drug, osteoporosis drug and so forth.
本发明涉及一种甲烷二膦酸酯衍生物,其制造工艺和药用应用,其表示如下式:##STR1##(其中,B为氢、烷基、羟基、烷氧基或氨基,D为硫、氧、NH、烷基取代的N、CH.sub.2或SCH.sub.2,X代表烷基、具有杂原子的烷基取代基、芳基或酰基,m表示1到5的整数,R.sup.1、R.sup.2、R.sup.3和R.sup.4分别代表氢、具有1到7个碳原子的烷基或药学上允许的阳离子)。本发明的化合物具有优异的IL-1抑制作用、抗氧化作用和抑制骨吸收作用,并可用作抗炎药、抗风湿药、骨代谢疾病药、自身免疫疾病药、骨质疏松症药等。